Patents by Inventor Andrew Morgan Stewart

Andrew Morgan Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11426411
    Abstract: The invention is directed to a method of treatment for inflammation in mammals including inflammation caused by bacterial or viral infection, the method comprising administering to a mammal, including a human, in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: August 30, 2022
    Assignee: MediSynergics, LLC
    Inventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
  • Patent number: 11007200
    Abstract: The invention is directed to a method of treatment for pain, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: May 18, 2021
    Assignee: MediSynergics, LLC
    Inventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
  • Publication number: 20210060023
    Abstract: The invention is directed to a method of treatment for inflammation in mammals including inflammation caused by bacterial or viral infection, the method comprising administering to a mammal, including a human, in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 19, 2020
    Publication date: March 4, 2021
    Applicant: Medisynergics, LLC
    Inventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart
  • Publication number: 20210052594
    Abstract: The invention is directed to a method of treatment for pain, the method comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 21, 2020
    Publication date: February 25, 2021
    Applicant: MediSynergics, LLC
    Inventors: Dennis Michael Godek, Harry Ralph Howard, Andrew Morgan Stewart